REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Icare Rx (Kamunting) Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers | Pharmacies and Drug Stores
Full name: Icare Rx (Kamunting) Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Stores specialized in retail sale of pharmaceuticals, medical and orthopaedic goods;import of pharmaceutical and medical goods;wholesale of pharmaceutical and medical goods

Headquarters
No. 356 & 358, Jalan Kamunting
Kamunting; Perak; Postal Code: 34600

Contact Details: Purchase the Icare Rx (Kamunting) Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Icare Rx (Kamunting) Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Icare Rx (Kamunting) Sdn. Bhd. report to view the information.
Incorporation Date:
May 08, 2019
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Icare Rx (Kamunting) Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-13.05%▼
Total operating revenue
-13.05%▼
Operating profit (EBIT)
-52.49%▼
Net Profit (Loss) for the Period
-52.48%▼
Total assets
10.62%▲
Total equity
15.63%▲
Operating Profit Margin (ROS)
-2.4%▼
Net Profit Margin
-1.98%▼
Return on Equity (ROE)
-19.37%▼
Debt to Equity Ratio
-0.83%▼
Quick Ratio
0.33%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo